Oral presentation of CARTITUDE-1 study data showcases long-term outcomes after a single infusion of CARVYKTI ® with one-third of patients with relapsed/refractory multiple myeloma progression-free for ...

Amgen today announced new interim results from the global Phase 3 DeLLphi-304 trial showing IMDELLTRA® (tarlatamab-dlle) reduced the risk of death by 40% and significantly extended median overall ...

In the heart of Denver’s charming Bonnie Brae neighborhood sits a dessert destination that has Coloradans willingly standing in line during snowstorms, heatwaves, and everything in between.

What started with an audition that consisted of Dave Mustaine warming up, ended two years later with a split from Metallica on the brink of their debut album.

Interim REFRESH results demonstrating that among 67 patients (approximately half oxybate naïve, 37% switches from twice-nightly oxybates, and the remainder previous twice-nightly oxybate users); ...